| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/2006 | CN1245980C Oral slow-release and controlled-release preparation for curing depression |
| 03/22/2006 | CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245977C Liposome anti-neoplastic drugs and uses thereof |
| 03/22/2006 | CN1245976C Pharmaceutical formulations in hydroxypropylmenthyl cellulose capsules |
| 03/22/2006 | CN1245975C Medicinal composition for stabilizing delotadine in preparation |
| 03/22/2006 | CN1245974C Carvedilol |
| 03/22/2006 | CN1245973C Use of biochemical material for preparing medicine for preventing and treating disease caused by smooth muscle cell contraction in human organ |
| 03/22/2006 | CN1245972C Naringenin and its salt used for preparing cough suppressing resolving phlegm medicine |
| 03/22/2006 | CN1245971C Tea poly phenol soft capsule and its preparation process |
| 03/22/2006 | CN1245970C Tanshinone 11A used in preparing medicine for preventing and treating atherosclerosis |
| 03/22/2006 | CN1245969C Gossypol acetate raw material medicinal preparation for treating gynecopathy |
| 03/22/2006 | CN1245968C Method for preparing naproxen sodium slow release tablet |
| 03/22/2006 | CN1245967C Use of compound in making medicine |
| 03/22/2006 | CN1245966C Use of beta-adrenoceptor antagonists for manufacture of medicament for treatment of disorders of outer retina |
| 03/22/2006 | CN1245965C Application of curcumin for treating myodystrophy |
| 03/22/2006 | CN1245964C Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 03/22/2006 | CN1245963C Medicinal composition including bradycardiac substances and ist use |
| 03/22/2006 | CN1245962C Novel process |
| 03/22/2006 | CN1245961C Ultraviolet shielding adhesive preparation |
| 03/22/2006 | CN1245960C Non-oral preparation having three-layer structure |
| 03/22/2006 | CN1245958C Controlled release hydroxy-ketone |
| 03/22/2006 | CN1245956C Method for producing oral administration delay-control release verapamil hydrochloride micro balls |
| 03/22/2006 | CN1245955C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/22/2006 | CN1245939C Non-spherical and non-platelet pyrithione salts |
| 03/22/2006 | CN1245875C Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 03/22/2006 | CA2482380A1 Beta-parvin expression for use in diagnostic methods for assessment of breast cancer |
| 03/21/2006 | USRE39033 Synergystic mixture of benzothiazole fungicide and a heterocyclic amines such as N-dodecyl morpholine, used as microbiocides on substrates such as leather, lumber, paper, textile, soils or coatings |
| 03/21/2006 | USRE39030 Fluoxetine enteric pellets and methods for their preparation and use |
| 03/21/2006 | US7015353 Process for the production of 9-(Z)-retinoic acid |
| 03/21/2006 | US7015350 Mixed esters of dicarboxylic acids for use as pigment dispersants |
| 03/21/2006 | US7015347 Stable no-delivering compounds |
| 03/21/2006 | US7015346 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 03/21/2006 | US7015343 Ssequentially treating abietic acid calcium salt with acid, base and extracting with organic solvent to give abietic acid with less isomer; reacting abietic acid with Pd/C to provide dehydroabietic acid, then converting it to sulfodehydroabietic acid via sufonation, neutralizing with zinc or bismuth ion |
| 03/21/2006 | US7015338 Synthetic methods for preparing procyanidin oligomers |
| 03/21/2006 | US7015329 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015253 Regimen for treating prostate tissue and surgical kit for use in the regimen |
| 03/21/2006 | US7015252 comprises ubiquinones; decreasing amount of urinary 8-hydroxydeoxyquanosine in diabetic animals |
| 03/21/2006 | US7015251 Combinations of ceramide and chemotherapeutic agents for inducing tumor cell death |
| 03/21/2006 | US7015250 Hypotensive agents |
| 03/21/2006 | US7015249 Methods and compositions for treating diabetes |
| 03/21/2006 | US7015248 Use of abietic acid and derivatives thereof for inhibiting cancer |
| 03/21/2006 | US7015247 As analgesics, antipyretics, antiinflammatory compounds; cancer therapy, in veterinary medicine |
| 03/21/2006 | US7015246 Benzofuran derivatives |
| 03/21/2006 | US7015245 Formulation to enhance antioxidant potency of Vitamin E |
| 03/21/2006 | US7015244 Inhalable chemical debridement for COPD |
| 03/21/2006 | US7015243 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/21/2006 | US7015242 Antisecretory agents; potassium channel moderators; irritable bowel syndrome |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015240 Treatment of macular edema |
| 03/21/2006 | US7015238 Crystalline organic acid salt of amlodipine |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015233 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 03/21/2006 | US7015232 Stablizer retards cyclization and discoloration of quinapril |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015230 serine protease inhibitors comprising pyrimidinediones, used as anticoagulants for prophylaxis of cardiovascular disorders; thrombolytic agents |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015228 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances |
| 03/21/2006 | US7015227 Amino -benzenes, -pyridines, -pyrimidines, -pyrazines, -pyridazines, -pyrazoles; anticancer agents |
| 03/21/2006 | US7015226 Hormone inhibitors such as 3-[2(R)-aminopropylamino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-methylsulfonylbenzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione, used as anticarcinogenic agents and for prophylaxis of glandular or urogenital disorders |
| 03/21/2006 | US7015225 carotenoids such as 3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid [2-(pyridin-2-yloxy)-ethyl]-amide used as preferential apoptosis inducing agents for prophylaxis of cancer or lymphoma; antitumor agents |
| 03/21/2006 | US7015224 7-Tert-butyl-3-(2-fluorophenyl)-6-(2H-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3b) pyridazine for the treatment of anxiety and convulsions |
| 03/21/2006 | US7015223 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| 03/21/2006 | US7015222 Agricultural compositions |
| 03/21/2006 | US7015221 2,4-disubstituted triazine derivatives |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015219 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
| 03/21/2006 | US7015215 Pyrrolo[2,1-c][1,4] benzodiazepines compounds and process thereof |
| 03/21/2006 | US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015212 Thiazepine inhibitors of HIV-1 integrase |
| 03/21/2006 | US7015211 steroids formulated in topical dosage form, as creams, gels or suppositories used for therapy or prohylaxis of symptoms associated with menopause |
| 03/21/2006 | US7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 03/21/2006 | US7015209 Hair-growing agent |
| 03/21/2006 | US7015208 carbocyclic alcohols such as 5-Chloro-2-methylsulfonylindan-1-ol and isomers, used as anorexigenic agents; side effect reduction; nontoxic |
| 03/21/2006 | US7015207 Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder |
| 03/21/2006 | US7015206 Use of a polysaccharide excreted by the Vibrio diabolicus species in bone repair |
| 03/21/2006 | US7015203 Macrolides |
| 03/21/2006 | US7015202 Adjust migration of monocytes, lymphocytes or interleukins; controllinginfections |
| 03/21/2006 | US7015201 Pyrazole derivatives and diabetic medicine containing them |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015199 Treatment of psoriasis through down-regulation of the EGF-receptor with topically-applied EGF |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015017 Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena |
| 03/21/2006 | US7015014 Isolation of carotenoid crystals |
| 03/21/2006 | US7015012 Obtaining a cell that expresses a fusion protein containing a glutamine-rich polypeptide and a fluorescent polypeptide; exposing the cell to a compound; incubating the cell, measuring second fluorescence emission |
| 03/21/2006 | US7014869 Rapid dehydration of proteins |
| 03/21/2006 | US7014867 Tablet comprising cetirizine and pseudoephedrine |
| 03/21/2006 | US7014866 High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same |
| 03/21/2006 | US7014864 contains fenofibrate and caprylic/capric/lauric triglycerides; for treatment of hyperlipidemia |
| 03/21/2006 | US7014863 Additive for an animal feed |